|
Table of Contents
About CVM
Mission Statement
CVM Organization Chart
Vision Statement
Guiding Principles
Introduction
A Brief History of CVM
Structure/ Responsibility
CVM Annual Reports
Safeguarding Animal Hlth
Office of the Director (OD)
Mgmt & Communications
CVM & Budget
Ofc of New Animal Drug
Surveillance/Compliance
Office of Research
|
| |
The Federal Food, Drug, and Cosmetic Act allows the Secretary
of Health and Human Services to delegate his or her authority
to others, such as the Commissioner of Food and Drugs. The Commissioner
has redelegated his or her authority for a number of functions
to CVM. Among these redelegated functions are:
-
Authority to approve New Animal Drug Applications and their
supplements and Abbreviated New Animal Drug Applications
(for generic drugs).
-
Authority to issue proposals, notices, and orders relating
to refusal to approve and withdrawal of approval of New
Animal Drug Applications and corresponding new animal drug
regulations.
-
Authority to approve the use of certain food additives.
The functions of the Office of the Director are as follows:
-
Directs overall Center activities and coordinates and establishes
Center policy in the areas of research, management, scientific
evaluation, compliance, and surveillance.
-
Directs systems for planning, programming, and budgeting
and provides administrative and information support for
the Center.
-
Plans and coordinates the Center's Equal Employment Opportunity
Program.
-
Approves New Animal Drug Applications (NADAs) and Abbreviated
New Animal Drug Applications (ANADAs), and issues notices
of withdrawal of new animal drug approvals when opportunities
for hearings have been waived.
-
Authorizes, for use as edible products, animals treated
with investigational drugs and terminates exemptions for
investigational trials.
-
Approves the use of animal food additives.
-
Ensures that industry submitted NADAs for food-producing
animals are reviewed and evaluated with respect to possible
effects on human health. The Director also serves as the
Center's representative and spokesperson concerning CVM
activities. The Director's contacts include the general
public, industry, other government agencies, and national
and international organizations.
CVM
Ombudsman
CVM Update
Dr. Tollefson Promoted
to Rear Admiral 8/16/01
Updated August 17, 2001 at 11:00 PM ET
|
|